FDA Offers Advice on Human Radiolabeled Mass Balance Studies
June 1, 2022
Human radiolabeled mass balance studies are the most direct way of gathering quantitative data on a drug’s absorption, distribution, metabolism and excretion (ADME) in the human body, according to draft guidance the FDA issued in early May.